Investments to strengthen its transmission and distribution infrastructure, rising demand from data centers, revenue decoupling and stable cash flow will boost operations.

Investments in product suite and go-to-market are positives for the company. Also, rising cyber security indicates continued positive growth for CyberArk, going forward.

Amedisys’ merger deal with Optum will seamlessly advance value-based care at home. Strong solvency bodes well.

Mondelez’s strategic pricing efforts are driving organic sales growth, while exciting new products and brand partnerships set the stage for continued success.

Phibro’s diversified product portfolio and wide presence in key-growth areas bolster our confidence in the stock. 

Early enrolments will drive education loan originations for Sallie Mae, thereby aiding its NII growth. Strategic inorganic growth moves will expand its operations and diversify revenue streams.

Kinross is making steady progress in advancing the projects that give it a strong growth profile among leading gold producers. Higher gold prices should also boost its profitability and cash flows. 

BILL benefits from growing revenues, strategic acquisitions, rich partner base, expanding small and medium businesses and a solid balance sheet.

Wheaton is poised to gain from its diversified portfolio of high-quality and long-life assets. Its strong cash position enables it to pay a competitive dividend and invest in accretive streams.

Royal Gold is likely to benefit from ramping up of new projects and solid streaming agreements. Focus on acquisitions and new business investments aided by a deleveraged strong balance sheet bode well.